Synapse - Darren Feldman

Search Within

Darren Richard Feldman

Results (349)

High-dose radiation therapy is needed for intracranial control and long-term survival in patients with non-seminomatous germ cell tumor brain metastases

Journal Article

Casey, D. L.; Pitter, K. L.; Imber, B. S.; Lin, A. L.; Chan, T. A.; Beal, K.; Yamada, Y.; Feldman, D. R.; Yang, T. J.
Journal of Neuro-Oncology (2019)

Fulltext@MSK | Save

Surgical management of patients with advanced germ cell tumors following salvage chemotherapy: Memorial Sloan Kettering Cancer Center (MSKCC) experience

Journal Article

Miller, M. I.; Feifer, A.; Feldman, D. R.; Carver, B. S.; Bosl, G. J.; Motzer, R. J.; Bajorin, D. F.; Sheinfeld, J.
Urology (2019)

Fulltext@MSK | Save

Characterizing recurrent and lethal small renal masses in clear cell renal cell carcinoma using recurrent somatic mutations

Journal Article

Manley, B. J.; Reznik, E.; Ghanaat, M.; Kashan, M.; Becerra, M. F.; Casuscelli, J.; Tennenbaum, D.; Redzematovic, A.; Carlo, M. I.; Sato, Y.; more...
Urologic Oncology: Seminars and Original Investigations (2019)

Fulltext@MSK | Save

Datasets for the reporting of neoplasia of the testis: Recommendations from the International Collaboration on Cancer Reporting

Review

Berney, D. M.; Comperat, E.; Feldman, D. R.; Hamilton, R. J.; Idrees, M. T.; Samaratunga, H.; Tickoo, S. K.; Yilmaz, A.; Srigley, J. R.
Histopathology (2019)

Fulltext@MSK | Save

Survivorship care

Book Section

Tonorezos, E.; Baxi, S. S.; Blinder, V.; Feldman, D. R.; Friedman, D. N.; Matasar, M.; Salz, T.; Shahrokni, A.; Oeffinger, K. C.
In The American Cancer Society (Eds.) The American Cancer Society's Principles of Oncology: Prevention to Survivorship (2018)

Fulltext@MSK | Save

Adjuvant etoposide plus cisplatin (EP) for pathologic stage (PS) II nonseminomatous germ cell tumor (NSGCT)

Meeting Abstract

McHugh, D. J.; Funt, S.; Silber, D.; Knezevic, A.; Patil, S.; O'Donnell, D.; Tsai, S.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Single-center analysis of 109 patients (pts) with metastatic chromophobe renal cell carcinoma (ChRCC): Differences in outcomes by histologic variant

Meeting Abstract

Ged, Y.; Knezevic, A.; Chen, Y.; Redzematovic, A.; Carlo, M. I.; Lee, C. H.; Feldman, D. R.; Patil, S.; Motzer, R. J.; Voss, M. H.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Etoposide and cisplatin (EP) for metastatic good-risk germ cell tumors (GCTs): The Memorial Sloan-Kettering Cancer Center (MSKCC) experience in 944 patients (pts)

Meeting Abstract

Funt, S.; McHugh, D. J.; Tsai, S.; O'Donnell, D.; Knezevic, A.; Patil, S.; Silber, D.; Reuter, V. E.; Sheinfeld, J.; Carver, B. S.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

ECOG score analysis as a proxy for health-related quality of life assessment in patients with poor or intermediate risk metastatic renal cell carcinoma from the CABOSUN trial (Alliance A031203)

Meeting Abstract

Feldman, D. R.; Feuilly, M.; Meng, J.; Lister, J.; Marteau, F.; Morris, M. J.; George, D. J.; Choueiri, T. K.
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save

Multicenter randomized phase 2 trial of paclitaxel, ifosfamide, and cisplatin (TIP) versus bleomycin, etoposide, and cisplatin (BEP) for first-line treatment of patients (pts) with intermediate- or poor-risk germ cell tumors (GCT)

Meeting Abstract

Feldman, D. R.; Hu, J.; Srinivas, S.; Stadler, W. M.; Costello, B. A.; Appleman, L. J.; Milowsky, M. I.; Patil, S.; Bromberg, M.; Nolan, P.; more...
Journal of Clinical Oncology (2018)

Fulltext@MSK | Save